According to a new report, published by KBV research, The Global Drug Discovery Informatics Market size is expected to reach $6.5 billion by 2031, rising at a market growth of 10.3% CAGR during the forecast period.
Healthcare IT systems and data analytics platforms play a crucial role in the growth and development of the drug discovery informatics market. By facilitating the integration and interoperability of diverse healthcare data sources, including electronic health records (EHRs), clinical trial data, genomic data, and imaging data. Drug discovery informatics leverages these integrated datasets to gain comprehensive insights into disease mechanisms, patient populations, and treatment outcomes, enabling more informed decision-making in drug discovery.
The Drug Development segment is anticipated to grow at a CAGR of 11.1% during (2024 - 2031). Drug discovery informatics platforms analyze biological data to identify and validate potential drug targets implicated in disease pathways, such as proteins, enzymes, or receptors. Computational methods help prioritize these targets based on druggability, specificity, and potential therapeutic impact.
The Sequencing & Target Data Analysis segment is leading the Global Drug Discovery Informatics Market by Function in 2023, thereby achieving a market value of $1.8 billion by 2031. This involves the analysis of genetic material, such as DNA or RNA sequences, obtained from various sources like human samples or pathogens. The goal is to understand the genetic makeup of organisms and identify variations that may be linked to diseases or other traits.
The Biotechnology Companies segment is poised to grow at a CAGR of 10.9% during (2024 - 2031). Through innovative approaches and strategic investments, biotechnology companies are at the forefront of leveraging advanced technologies and computational methods to streamline the drug discovery process. They harness high-throughput technologies, such as next-generation sequencing and omics technologies, to generate vast amounts of biological data, necessitating sophisticated informatics solutions for data management, analysis, and interpretation.
Full Report: https://www.kbvresearch.com/drug-discovery-informatics-market/
The North America region dominated the Global Drug Discovery Informatics Market by Region in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.4 billion by 2031. The Europe region is exhibiting a CAGR of 9.9% during (2024 - 2031). Additionally, The Asia Pacific region would experience a CAGR of 10.9% during (2024 - 2031).
By Application
By Function
By End User
Unique Offerings 
